Perivascular cell‐derived extracellular vesicles stimulate colorectal cancer revascularization after withdrawal of antiangiogenic drugs

Antiangiogenic tyrosine kinase inhibitors (AA‐TKIs) have become a promising therapeutic strategy for colorectal cancer (CRC). In clinical practice, a significant proportion of cancer patients temporarily discontinue AA‐TKI treatment due to recurrent toxicities, economic burden or acquired resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Maohua, Chen, Minfeng, Qi, Ming, Ye, Geni, Pan, Jinghua, Shi, Changzheng, Yang, Yunlong, Zhao, Luyu, Mo, Xukai, Zhang, Yiran, Li, Yong, Zhong, Jincheng, Lu, Weijin, Li, Xiaobo, Zhang, Jiayan, Lin, Jinrong, Luo, Liangping, Liu, Tongzheng, Tang, Patrick Ming‐Kuen, Hong, An, Cao, Yihai, Ye, Wencai, Zhang, Dongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138700/
https://www.ncbi.nlm.nih.gov/pubmed/34035882
http://dx.doi.org/10.1002/jev2.12096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138700/
https://www.ncbi.nlm.nih.gov/pubmed/34035882
http://dx.doi.org/10.1002/jev2.12096

Ejemplares similares